[Model concept of the health economic evaluation of low-dose CT lung cancer screening in Hungary]

Orv Hetil. 2017 Jun;158(25):963-975. doi: 10.1556/650.2017.30731.
[Article in Hungarian]

Abstract

Introduction: Lung cancer is a rapidly progressing, often life-threatening disease that constitutes a huge societal burden. Because of the scarce resources of the Hungarian health care system, the cost-effectiveness of introducing low-dose computed tomography screening is a relevant health policy matter.

Aim: The aim of this study is to design a model concept for assessing the cost-effectiveness of low-dose computed tomography lung cancer screening in Hungary, and to define the required steps for performing the analysis.

Method: A targeted literature review was conducted to identify and synthesize the evidence on efficacy and effectiveness of screening, and results were evaluated based on adaptability to Hungarian settings. We also summarized the available Hungarian scientific evidence and reconstructed the potential patient pathways.

Results: In accordance with these findings, we recommend to perform the full health-economic evaluation of low-dose computed tomography lung cancer screening using a complex model structure that consists of several sub-models and is capable to follow the population at risk on life-time horizon.

Conclusions: The proposed cost-effectiveness model will be suitable to provide data for further analyses that support decision-making on introducing low-dose computed tomography lung cancer screening as public health program. Orv Hetil. 2017; 158(25): 963-975.

Keywords: Hungary; alacsony dózisú CT; cost-effectiveness; egészség-gazdaságtani modell; health economic model; költség-hatékonyság; low-dose CT; lung cancer screening; tüdőrákszűrés.

MeSH terms

  • Cost-Benefit Analysis
  • Early Detection of Cancer / economics*
  • Female
  • Humans
  • Hungary
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / economics*
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / prevention & control
  • Male
  • Mass Screening / economics*
  • Patient Selection
  • Tomography, Spiral Computed / economics*